Cite
MLA Citation
Vanesa Gregorc et al.. “NGR-hTNF in combination with best investigator choice in previously treated malignant pleural mesothelioma (NGR015): a randomised, double-blind, placebo-controlled phase 3 trial.” Lancet oncology, vol. 19, no. 6, 2018, pp. 799–811. http://access.bl.uk/ark:/81055/vdc_100065599900.0x00000f